Background: The present study aims to investigate the correlation between resilience, self-efficacy, and illness perception in patients with type 2 diabetes mellitus in the south of Iran. Materials and methods: The present study is a crosssectional work conducted on 405 patients with type 2 diabetes mellitus who were selected via convenience sampling from clinics in the south of Iran, from December 2019 to July 2020. Data were collected using a questionnaire consisting of four sections: a demographics survey, the Connor-Davidson Resilience Scale (CD-RISC), Lev's Self-efficacy Scale, and Broadbent's Brief Illness Perception Questionnaire (BIPQ). Data analysis was performed in SPSS 22 software using descriptive statistics, Pearson correlation, ANOVA, and multiple regression analysis at a p < 0.05 significance level. Results: The results of the study showed that there were significant positive correlations between the participants' resilience and self-efficacy (r = 0.78, p < 0.001), resilience and illness perception (r = 0.57, p < 0.001), and self-efficacy and illness perception (r = 0.76, p < 0.001). Conclusions: The findings of the present study show that there is a positive correlation between resilience and self-efficacy and illness perception in patients with type 2 diabetes mellitus. patients with diabetes who can successfully cope with the traumatic conditions caused by their illness and have confidence in their ability to perform self-care activities have a more positive view of the manageability of their condition. Therefore, healthcare policymakers and nurses can use interventions designed to enhance resilience and self-efficacy in order to improve diabetic patients' illness perception and management. (Clin Diabetol 2022, 11; 3: 175-182
Pregnant women are one of the vulnerable groups against COVID-19. Understanding the affected population characteristics helps to identify risk factors and set more effective treatment goals; in this regard, the present study tries to review demographic characteristics, clinical signs, radiological and laboratory findings in pregnant women with COVID-19 in southern Iran.Methods: This descriptive cross-sectional study was conducted on 30 pregnant women with COVID-19 who were selected from teaching hospitals in Fasa, Jahrom, and Shiraz in Fars province. Sampling was done through the convenience method from March to July 2020. A researcher-made checklist was applied to gather the required data which were analyzed using SPSS 22 software and descriptive statistics. Results:The mean age of patients was 28.30±9.96 years. Of patients, 60% were in the first trimester of pregnancy. The average length of stay in a hospital was 8.47±4.37 days. Fever (46/66 %) was the most common clinical finding, increased C-reactive protein (CRP) levels (50%) was the most common laboratory finding, and Ground Glossy Opacity (GGO) (56/66 %) was the most common radiological finding in both lungs. Of pregnant women, 80% with COVID-19 had an underlying disease. The most common underlying diseases were 36.66% for asthma and 20% for diabetes. Of normal deliveries, 53.33% and 3.33% of neonatal and maternal deaths were reported. Conclusion:The most common time for COVID-19 in pregnant women was reported in the first trimester of pregnancy with clinical signs of fever and a history of asthma and diabetes. Therefore, the findings of this study highlight the importance of paying attention to pregnant women as one of the most at-risk groups in the COVID-19 pandemic. Health policy makers can use the findings of this study and the reported outcomes to develop appropriate health protocols for health care of pregnant women in the COVID-19 pandemic.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.